Cargando…
Retraction: MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions
Retraction of ‘MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions’ by Qiang He et al., RSC Adv., 2019, 9, 1717–1725, DOI: 10.1039/C8RA09229J
Autor principal: | Fisher, Laura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694493/ https://www.ncbi.nlm.nih.gov/pubmed/35426999 http://dx.doi.org/10.1039/d1ra90022f |
Ejemplares similares
-
Retracted Article: MiR-206 reduced the malignancy of hepatocellular carcinoma cells in vitro by inhibiting MET and CTNNB1 gene expressions
por: He, Qiang, et al.
Publicado: (2019) -
Retracted: miR-206 Inhibits Laryngeal Carcinoma Cell Multiplication, Migration, and Invasion
por: Healthcare Engineering, Journal of
Publicado: (2023) -
Retraction: MiR-182-5p and miR-96-5p increased hepatocellular carcinoma cell mobility, proliferation and cisplatin resistance partially by targeting RND3
por: Fisher, Laura
Publicado: (2021) -
[Retracted] miR‑206 inhibits cancer initiating cells by targeting EHF in gastric cancer
por: Gong, Yan-Cui, et al.
Publicado: (2023) -
MicroRNA-206 Reduces Osteosarcoma Cell Malignancy In Vitro by Targeting the PAX3-MET Axis
por: Zhan, Fang-Biao, et al.
Publicado: (2019)